CLOV (Clover Health Investments) Ending Cash Position: $173 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLOV Clover Health Investments Corp CLOV
83 GF Score
Price $4.50
GF Value $4.05
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Clover Health Investments Ending Cash Position?

Clover Health Investments CLOV -2.39% 83 Ending Cash Position is $173 Mil as of Mar. 2026. GuruFocus rates CLOV with a GF Score™ of 83/100 and a GF Value™ of $4.05 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Clover Health Investments's Ending Cash Position for the quarter that ended in Mar. 2026 was $173 Mil.

Clover Health Investments's quarterly Ending Cash Position declined from Sep. 2025 ($190 Mil) to Dec. 2025 ($78 Mil) but then increased from Dec. 2025 ($78 Mil) to Mar. 2026 ($173 Mil).

Clover Health Investments's annual Ending Cash Position increased from Dec. 2023 ($176 Mil) to Dec. 2024 ($195 Mil) but then declined from Dec. 2024 ($195 Mil) to Dec. 2025 ($78 Mil).

Clover Health Investments Ending Cash Position Related Terms

Clover Health Investments Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Ending Cash Position Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 299.97 186.21 176.49 194.54 78.30

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 155.44 188.65 190.06 78.30 173.27
CLOV
83GF Score
Clover Health Investments Corp CLOV
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Clover Health Investments's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=194.543+-116.242
=78

Clover Health Investments's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=78.301+94.964
=173

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $173 Mil mean?
Clover Health Investments (CLOV) has a Ending Cash Position of $173 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Clover Health Investments and its competitors.
Is Clover Health Investments' Ending Cash Position too high?
Clover Health Investments' current Ending Cash Position is $173 Mil. Overall, Clover Health Investments has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Ending Cash Position compare to PGNY and ALHC?
Clover Health Investments' Ending Cash Position of $173 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Plans company?
A good Ending Cash Position depends on the Healthcare Plans industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current Ending Cash Position is $173 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.05, compared to a current price of $4.50 — trading 11.1% above its estimated fair value. The current Ending Cash Position is $173 Mil. Clover Health Investments' overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Ending Cash Position is $173 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $4.50 is trading 11.1% above its estimated GF Value™ of $4.05. GuruFocus considers Clover Health Investments to be Modestly Overvalued.

Key valuation signals for CLOV:

  • Ending Cash Position: $173 Mil
  • GF Value™: $4.05 vs. price of $4.50 (11.1% above fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
83GF Score

Get the complete analysis for CLOV

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.50
Price
$4.05
GF Value